Chemical & Biologial Defense News

World Health Organization Workshop on Plague Vaccine Evaluation

Posted by: steven lusher | Apr 23, 2018 |

Dr. Lucy Ward, Senior Scientist for the Joint Vaccine Acquisition Program (JVAP) product management office under the Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) participated in a panel discussion on April 23, 2018 on JVAP's advanced development of a vaccine to protect against plague. The World Health Organization hosted the Workshop on Plague Vaccine Evaluation in Paris, France to discuss recent trends in plague vaccine development. JVAP develops, produces, and fields Food and Drug Administration-licensed biological defense vaccines. JPM-MCS is one of the five JPMs under the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense.

2018April23_MCSJVAP_rF1VVaccine_WHO_Panel version (003)